Biomedomics is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.
Trademark Applications
Trademark applications show the products and services that Biomedomics is developing and marketing.
Biomedomics doesn't have any recent trademark applications, indicating Biomedomics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
FUNGI SCAN chemical reagents for medical purposes used to stain biological samples, such as skin, nail, dandruff samples, and the like, to detect fungal infection
08/11/2017
HEMO SCAN Kits comprised of test cassettes, medical diagnostic reagents and instructions, for use in the detection and diagnosis of diseases and disorders in subjects
03/11/2015
THAL SCAN Kits comprised of test cassettes, medical diagnostic reagents and instructions, for use in the detection and diagnosis of diseases and disorders in subjects
03/11/2015
See all trademarks and details in the Full Report.
Market Share of Biomedomics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Biomedomics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Biomedomics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Biomedomics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.